Health Economics and Policy

Through innovative methods of educating, screening and diagnosing the world’s population, we can win the battle against glaucoma

Anti-inflammatories that reduce patient adherence or offer a more reliable delivery mechanism are driving the evolution of postoperative regimens

Women are the disproportionate victims of avoidable blindness – they need to be put at the center of global advocacy work

The Icare HOME tonometer enables 24-hour IOP monitoring – any time, any place

Sitting down with… Keith Martin, Ringland Anderson Professor and Head of Ophthalmology, University of Melbourne

Could a novel formulation technology offer an injection-free alternative for diabetic macular edema patients?

To unlock the full potential of machine learning for ophthalmology, the industry needs to determine responsible policies and best practices

Large-scale analysis of clinical trial data involves numerous challenges and significant manpower. Can deep learning facilitate the process?

Combining genetic testing with AI and machine learning offers virtually unlimited opportunities in disease detection, management, and treatment

The future of eye care will rely on artificial intelligence-driven imaging interpretation – in the clinic and out